Literature DB >> 20215562

A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme.

Liisa Laakkonen1, Moshe Finel.   

Abstract

The vertebrate UDP-glucuronosyltransferases (UGTs) are membrane-bound enzymes of the endoplasmic reticulum that process both endogenous and exogenous substrates. The human UGTs are well known biologically, but biophysical understanding is scarce, largely because of problems in purification. The one resolved crystal structure covers the C-terminal domain of the human UGT2B7. Here, we present a homology model of the complete monomeric human UGT1A1, the enzyme that catalyzes bilirubin glucuronidation. The enzyme can be seen as composed of four different domains: two large ones, the N- and C-terminal domains, and two small ones, the "envelope" helices and the transmembrane segment that includes the cytoplasmic tail. The hydrophobic core of the N-terminal domain and the two envelope helices that connect the large domains are shown to be structurally well conserved even among distant homologs and can thus be modeled with good certainty according to plant and bacterial structures. We consider alternative solutions for the highly variable N-terminal regions that probably contribute to substrate binding. The bilirubin binding site, known pathological mutations in UGT1A1, and other specific residues have been examined in the context of the model with regard to available experimental data. A putative orientation of the protein relative to the membrane has been derived from the location of predicted N-glycosylation sites. The model presents extensive interactions between the N- and C-terminal domains, the two envelope helices, and the membrane. Together, these interactions could allow for a concerted large-scale conformational change during catalysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215562     DOI: 10.1124/mol.109.063289

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  23 in total

1.  Accurate prediction of glucuronidation of structurally diverse phenolics by human UGT1A9 using combined experimental and in silico approaches.

Authors:  Baojian Wu; Xiaoqiang Wang; Shuxing Zhang; Ming Hu
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

Review 2.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

Review 3.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

4.  Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes.

Authors:  Michael J Osborne; Luciana Coutinho de Oliveira; Laurent Volpon; Hiba Ahmad Zahreddine; Katherine L B Borden
Journal:  J Mol Biol       Date:  2018-11-11       Impact factor: 5.469

5.  Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis.

Authors:  Ryan T Bushey; Gang Chen; Andrea S Blevins-Primeau; Jacek Krzeminski; Shantu Amin; Philip Lazarus
Journal:  Pharmacogenet Genomics       Date:  2011-02       Impact factor: 2.089

6.  The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants.

Authors:  Zi-Zhao Yang; Li Li; Lu Wang; Ling-Min Yuan; Ming-Cheng Xu; Jing-Kai Gu; Hui-di Jiang; Lu-Shan Yu; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2017-05-29       Impact factor: 6.150

7.  Phenylalanine 93 of the human UGT1A10 plays a major role in the interactions of the enzyme with estrogens.

Authors:  Camilla Höglund; Nina Sneitz; Anna Radominska-Pandya; Liisa Laakonen; Moshe Finel
Journal:  Steroids       Date:  2011-08-09       Impact factor: 2.668

8.  Identification and functional characterization of a novel UDP-glucuronosyltransferase 2A1 splice variant: potential importance in tobacco-related cancer susceptibility.

Authors:  Ryan T Bushey; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2012-09-13       Impact factor: 4.030

9.  Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells.

Authors:  Yingjie Wei; Baojian Wu; Wen Jiang; Taijun Yin; Xiaobin Jia; Sumit Basu; Guangyi Yang; Ming Hu
Journal:  Mol Pharm       Date:  2013-04-23       Impact factor: 4.939

10.  Establishment and use of new MDCK II cells overexpressing both UGT1A1 and MRP2 to characterize flavonoid metabolism via the glucuronidation pathway.

Authors:  Meifang Wang; Guangyi Yang; Yu He; Beibei Xu; Min Zeng; Shufan Ge; Taijun Yin; Song Gao; Ming Hu
Journal:  Mol Nutr Food Res       Date:  2016-07-06       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.